688056 莱伯泰科
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.8793.2895.5339.09512.226
总资产报酬率 ROA (%)2.4602.8044.8147.95610.017
投入资产回报率 ROIC (%)2.6653.0375.1938.56111.583

边际利润分析
销售毛利率 (%)44.69143.79147.70948.43748.612
营业利润率 (%)11.8876.84314.44720.87019.858
息税前利润/营业总收入 (%)11.0376.05613.76921.90521.985
净利润/营业总收入 (%)11.1366.62612.57018.81818.731

收益指标分析
经营活动净收益/利润总额(%)90.78595.04991.00884.52991.664
价值变动净收益/利润总额(%)9.91812.89410.2989.1300.978
营业外收支净额/利润总额(%)-0.058-0.108-0.1846.0209.406

偿债能力分析
流动比率 (X)6.1695.3775.9587.2557.074
速动比率 (X)4.7614.2424.7606.2636.261
资产负债率 (%)13.56315.44814.02511.88213.076
带息债务/全部投入资本 (%)5.2087.8466.1935.0075.652
股东权益/带息债务 (%)1,801.4251,165.1681,506.3601,886.7101,659.344
股东权益/负债合计 (%)637.292547.333613.024741.585664.010
利息保障倍数 (X)-13.086-7.775-21.166-72.601339.824

营运能力分析
应收账款周转天数 (天)49.00245.23448.08940.70246.068
存货周转天数 (天)254.613249.917249.236177.735177.440